Totally video-guided thoracoscopic mitral valve surgery resulted in a 0.8% in-hospital mortality rate, a 3.0% all-cause mortality rate at 5 years, and a 1.7% 5-year reoperation rate.
Cohort (n=368)
No
What are the early and mid-term clinical outcomes of totally video-guided thoracoscopic surgery for mitral valve repair?
Totally video-guided thoracoscopic mitral valve surgery demonstrates excellent early and mid-term safety and efficacy, with low rates of mortality, major adverse events, and reoperation.
Totally video-guided thoracoscopic surgery (TVTS) has emerged as a minimally invasive alternative to conventional surgery with full sternotomy for mitral valve surgery. Evaluation of clinical outcomes of TVTS mitral valve surgery is essential for guiding patient selection and surgical planning. We conducted a retrospective study of 368 consecutive patients who underwent TVTS for mitral valve repair at a tertiary academic center to evaluate the safety and efficacy of this minimally invasive approach. Mitral valve repair was accomplished using the respect technique in 96.4% %, using two PTFE artificial-cordae on the posterior leaflet in 61.7% of patients. In-hospital mortality was 0.8%, stroke 1.2% and ECMO support was required for 1.4% of patients. The median follow-up was 2.5 years (q1; q3 1.18;4.15) and it was complete in 98.6% of patients. At 5-year, all-cause mortality was 3.0% and the rate of major cardiac and cerebrovascular events and reoperations were respectively 1.9% and 1.7%. Provided adequate surgical expertise, TVTS mitral valve surgery can be performed with good early and mid-clinical outcomes.
Mastroiacovo et al. (Tue,) conducted a cohort in Mitral regurgitation (n=368). Totally video-guided thoracoscopic surgery (TVTS) was evaluated on 5-year all-cause mortality. Totally video-guided thoracoscopic mitral valve surgery resulted in a 0.8% in-hospital mortality rate, a 3.0% all-cause mortality rate at 5 years, and a 1.7% 5-year reoperation rate.